Your browser doesn't support javascript.
loading
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
Soria, Jean-Charles; Tan, Daniel S W; Chiari, Rita; Wu, Yi-Long; Paz-Ares, Luis; Wolf, Juergen; Geater, Sarayut L; Orlov, Sergey; Cortinovis, Diego; Yu, Chong-Jen; Hochmair, Maximillian; Cortot, Alexis B; Tsai, Chun-Ming; Moro-Sibilot, Denis; Campelo, Rosario G; McCulloch, Tracey; Sen, Paramita; Dugan, Margaret; Pantano, Serafino; Branle, Fabrice; Massacesi, Cristian; de Castro, Gilberto.
Afiliação
  • Soria JC; University Paris-Sud, Orsay, France; Institut Gustave Roussy, Villejuif, France. Electronic address: Jean-Charles.Soria@gustaveroussy.fr.
  • Tan DSW; National Cancer Centre Singapore and Genome Institute of Singapore, Singapore.
  • Chiari R; Azienda Ospedale Perugia, Perugia, Italy.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Paz-Ares L; University Hospital Virgen del RocioDoce de Octubre, Universidad Complutense & CNIO, Madrid, Spain.
  • Wolf J; University Hospital Cologne, Cologne, Germany.
  • Geater SL; Songklanagarind Hospital, Songkla, Thailand.
  • Orlov S; State Pavlov Medical University, St Petersburg, Russia.
  • Cortinovis D; Az. Ospedaliera San Gerardo, Monza, Italy.
  • Yu CJ; National Taiwan University Hospital, Taipei, Taiwan.
  • Hochmair M; Respiratory Oncology Unit, Department of Respiratory and Critical Care Medicine, Otto-Wagner-Spital, Vienna, Austria.
  • Cortot AB; CHU de LILLE, Lille, France.
  • Tsai CM; Taipei Veterans General Hospital, Taipei, Taiwan.
  • Moro-Sibilot D; Hôpital Albert Michallon, Grenoble, France.
  • Campelo RG; University Hospital A Coruña, La Coruna, Spain.
  • McCulloch T; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Sen P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Dugan M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Pantano S; Novartis Pharma AG, Basel, Switzerland.
  • Branle F; Novartis Pharma AG, Basel, Switzerland.
  • Massacesi C; Novartis Pharma AG, Basel, Switzerland.
  • de Castro G; Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.
Lancet ; 389(10072): 917-929, 2017 03 04.
Article em En | MEDLINE | ID: mdl-28126333
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article